The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis
Abstract
Background: Despite the long experience with radioiodine for hyperthyroidism, controversy remains regarding the optimal method to determine the activity that is required to achieve long-term euthyroidism. Objectives: To compare the effect of estimated versus calculated activity of radioiodine in hyperthyroidism. Design: Systematic review and meta-analysis. Methods: We searched the databases Medline, EMBASE, Web of Science, and Cochrane Library for randomized and nonrandomized studies, comparing the effect of activity estimation methods with dosimetry for hyperthyroidism. The main outcome measure was the frequency of treatment success, defined as persistent euthyroidism after radioiodine treatment at the end of follow-up in the dose estimated and calculated dosimetry group. Furthermore, we assessed the cure rates of hyperthyroidism. Results: Three randomized and five nonrandomized studies, comparing the effect of estimated versus calculated activity of radioiodine on clinical outcomes for the treatment of hyperthyroidism, were included. The weighted mean relative frequency of successful treatment outcome (euthyroidism) was 1.03 (95% confidence interval (CI) 0.91–1.16) for estimated versus calculated activity; the weighted mean relative frequency of cure of hyperthyroidism (eu- or hypothyroidism) was 1.03 (95% CI 0.96–1.10). Subgroup analysis showed a relative frequency of euthyroidism of 1.03 (95% CI 0.84–1.26) for Graves' disease and of 1.05 (95% CI 0.91–1.19) for toxic multinodular goiter. Conclusion: The two main methods used to determine the activity in the treatment of hyperthyroidism with radioiodine, estimated and calculated, resulted in an equally successful treatment outcome. However, the heterogeneity of the included studies is a strong limitation that prevents a definitive conclusion from this meta-analysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This outcome can be accomplished equally well by either administering a fixed activity or by calculating the activity based on the size of the thyroid and its ability to trap RAI (85).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [85]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Wartofsky, L., Glinoer, D., Solomon, B. L., Nagataki, S., Lagasse, R., Nagayama, Y., & Izumi, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
Current Trends in the Management of Graves' Disease*
Solomon, B. L., Glinoer, D., Lagasse, R., & Wartofsky, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266
A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism
Leslie, W. D., Ward, L., Salamon, E. A., Ludwig, S., Rowe, R. C., & Cowden, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020805 · Cited by 204
Long‐term follow‐up study of radioiodine treatment of hyperthyroidism
Metso, S., Jaatinen, P., Huhtala, H., Luukkaala, T. H., Oksala, H., & Salmi, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02152.x · Cited by 204
Walter, M. A., Briel, M., Christ-Crain, M., Bonnema, S. J., Connell, J., Cooper, D. S., Bucher, H. C., Müller-Brand, J., & Müller, B. (2007) · BMJ · doi:10.1136/bmj.39114.670150.be · Cited by 202
PETERS, H., FISCHER, C., BOGNER, U., REINERS, C., & SCHLEUSENER, H. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01547.x · Cited by 174
Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv, A. E., Hegedüst, L., Kristensen, L. Ø., Nygaard, B., & Hansen, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02039.x · Cited by 155
Long‐term follow‐up of treatment of thyrotoxicosis by three different methods
Franklyn, J. A., Daykin, J., Drolc, Z., Farmer, M. J., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01738.x · Cited by 139
Treatment of Graves' Hyperthyroidism with Radioiodine: Results of a Prospective Randomized Study
PETERS, H., FISCHER, C., BOGNER, U., REINERS, C., & SCHLEUSENER, H. (1997) · Thyroid · doi:10.1089/thy.1997.7.247 · Cited by 121
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“This outcome can be accomplished equally well by either administering a fixed activity or by calculating the activity based on the size of the thyroid and its ability to trap RAI (85).”
BackgroundDe Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Bonnema, S. J., & Hegedűs, L. D. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1030 · Cited by 340
Lee, S. L. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357fa0c · Cited by 307
“Calculated dose and dosimetry have been shown by meta-analysis to be equally effective [27].”
BackgroundFranklyn, J. A., & Boelaert, K. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60782-4 · Cited by 262
Metadata
- Authors
- de Rooij, A., Vandenbroucke, J. P., Smit, J. W. A., Stokkel, M. P. M., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Dekkers, O M
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 161
- Issue
- 5
- Pages
- 771-777
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2099188249
- Cited by
- 102
- References
- 26
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 10 · 2023: 2 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 6
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- radioiodine therapy, hyperthyroidism, euthyroidism, Graves' disease, toxic multinodular goiter, treatment success
- MeSH terms
- Dose-Response Relationship, Radiation, Humans, Hyperthyroidism, Iodine Radioisotopes, Radiotherapy Dosage, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
